Decavac Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


DECAVAC® is a vaccine indicated for active immunization for the prevention of tetanus and diphtheria. DECAVAC vaccine is approved for use in persons 7 years of age and older.


There is currently no drug history available for this drug.

Other Information

DECAVAC vaccine, Tetanus and Diphtheria Toxoids Adsorbed, for intramuscular injection, is a sterile suspension of alum (aluminum potassium sulfate)-precipitated toxoids in an isotonic sodium chloride solution. The vaccine, after shaking, is a turbid liquid, whitish-gray in color.

Corynebacterium diphtheriae cultures are grown in a modified Mueller and Miller medium. (5) Clostridium tetani cultures are grown in a peptone-based medium containing an extract of bovine muscle tissue. The bovine muscle tissue used in this medium is US sourced. Tetanus and diphtheria toxins produced during the growth of the cultures are detoxified with formaldehyde. The detoxified materials are then separately purified by serial ammonium sulfate fractionation and diafiltration, and adsorbed onto alum.

Each 0.5 mL dose of DECAVAC vaccine is formulated to contain the following active ingredients: 5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid. The tetanus and diphtheria toxoids induce at least 2 units and 0.5 units of antitoxin per mL of serum, respectively, in the guinea pig potency test. Each 0.5 mL dose also contains a trace amount of thimerosal [mercury derivative, (≤0.3 mcg mercury/dose) not as a preservative] from the manufacturing process, aluminum potassium sulfate adjuvant (not more than 0.28 mg aluminum by assay), and not more than 100 mcg (0.02%) of residual formaldehyde.

The tip caps of the prefilled syringes may contain natural rubber latex. No other components of any presentation contain latex.

Decavac Manufacturers

  • Sanofi Pasteur Inc.
    Decavac (Clostridium Tetani Toxoid Antigen (Formaldehyde Inactivated) And Corynebacterium Diphtheriae Toxoid Antigen (Formaldehyde Inactivated)) Suspension [Sanofi Pasteur Inc.]

Login To Your Free Account